QR-kod

The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia

Acute myeloid leukemia is a heterogeneous disease with a 5-year survival rate of 28.3%, and current treatment options constrained by dose-limiting toxicities. One of the key signaling pathways known to be frequently activated and dysregulated in AML is PI3K/AKT. Its dysregulation is associated with...

Full beskrivning

Sparad:
Huvudupphov: Charyguly Annageldiyev, Su-Fern Tan, Shreya Thakur, Pavan Kumar Dhanyamraju, Srinivasa R. Ramisetti, Preeti Bhadauria, Jacob Schick, Zheng Zeng, Varun Sharma, Wendy Dunton, Sinisa Dovat, Dhimant Desai, Hong Zheng, David J. Feith, Thomas P. Loughran, Shantu Amin, Arun K. Sharma, David Claxton, Arati Sharma
Materialtyp: Artigo
Språk:Inglês
Utgiven: Frontiers Media S.A. 2020-04-01
Serie:Frontiers in Oncology
Ämnen:
AML
isoselenocyanate-4
Akt
apoptosis
AraC
xenograft
Länkar:https://www.frontiersin.org/article/10.3389/fonc.2020.00393/full
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk